• Monthly News Roundup - September 2023

    Monthly News Roundup - September 2023
    Subcutaneous Form of Entyvio Approved for Ulcerative Colitis
    In addition to the intravenous (IV) formulation, the FDA has now approved subcutaneous (SC) Entyvio (vedolizumab) for maintenance therapy in adults with moderately-to-severely active...

Follow @PharmaIndustry_ on Twitter!